Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
212,015
Total Claims
$54.7M
Drug Cost
164,850
Beneficiaries
$332
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-98%
Opioid rate vs peers
0.1% vs 2.6% avg
-69%
Cost per patient vs peers
$332 vs $1,068 avg
+989%
Brand preference vs peers
98.0% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.1%
Opioid Rate
120
Opioid Claims
$4,330
Opioid Cost
10.0%
Long-Acting Rate
Brand vs Generic
Brand: 207,740 claims · $54.5M
Generic: 4,242 claims · $168K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rsvpref3 Antigen/As01e/Pf | 73,335 | $23.2M |
| Varicella-Zoster Ge/As01b/Pf | 77,369 | $16.6M |
| Rsv Vacc, Pref A And Pref B/Pf | 40,444 | $13.2M |
| Diphth,pertuss(Acell),tet Vac | 13,804 | $948K |
| Hepatitis A And B Vaccine/Pf | 956 | $142K |
| Naloxone Hcl | 1,024 | $78K |
| Hepatitis A Virus Vaccine/Pf | 305 | $32K |
| Typhoid Vi Polysacch Vaccine | 174 | $24K |
| Apixaban | 35 | $23K |
| Hpv Vaccine 9-Valent/Pf | 68 | $21K |
| Tetanus-Diphtheria Toxoids/Pf | 342 | $20K |
| Diph,pertuss(Acell),tet Vac/Pf | 224 | $16K |
| Rivaroxaban | 12 | $16K |
| Exenatide Microspheres | 14 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $13K |
Prescribing Profile
Patient Profile
74
Avg Age
58%
Female
1.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data